Simon Read

Insider Reports History

Location
New York, NY
Signature
/s/ Adam Veness, as attorney-in-fact for Simon Read
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Read:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 25,000 22 May 2025 Direct

Insider Reports Filed by Simon Read

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Dianthus Therapeutics, Inc. /DE/ 22 May 2025 1 $0 4 Director 22 May 2025, 16:40
DNTH Dianthus Therapeutics, Inc. /DE/ 22 May 2025 0 $0 3 Director 22 May 2025, 16:39